Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00870727
Recruitment Status : Completed
First Posted : March 27, 2009
Last Update Posted : March 16, 2018
National Institute of Mental Health (NIMH)
Bristol-Myers Squibb
Information provided by (Responsible Party):
Indiana University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2015
  Actual Study Completion Date : May 2015
  Certification/Extension First Submitted : April 6, 2017